Relapses with RTX Maintenance in ANCA-associated Vasculitis
A real-world study on ΜPA and GPA patients found that RTX maintenance had a 25% relapse risk, with lower rates when combined with cyclophosphamide treatment.
https://t.co/bD6u5JWVqS https://t.co/CSotJt4in1
Links:
Relapses with Rituximab Maintenance in ANCA-associated Vasculitis | RheumNow
https://buff.ly/3YDDsKy
Aug-10-2024


